Pharmacogenetics

Saturday, 13 April 2002

Organizers:
W. Kirch (Dresden, Germany)
U.I. Schwarz (Dresden, Germany)

Gene polymorphisms in drug therapy

Session I
Chairs R.B. Kim (Nashville, USA)
W. Kirch (Dresden, Germany)
9.30 – 10.00 Drug transporter Polymorphisms: An Overview
R.B. Kim (Nashville, USA)
10.00 – 10.30 Impact of MDR-1 polymorphisms on drug disposition
M.F. Fromm (Stuttgart, Germany)
10.30 – 11.00 Grapefruit-juice & drug transport
G.K. Dresser (London, Canada)
11.00 – 11.20 coffee break
11.20 – 11.50
CYP2D6
polymorphisms
I. Cascorbi (Greifswald, Germany)
11.50 – 12.20
CYP2C9
polymorphisms – implication for drug therapy
U.I. Schwarz (Dresden, Germany)
12.20 – 12.30 discussion, final remarks
12.30 end of workshop 1